Global Bone Density Testing Market

Bone Density Testing Comprehensive Study by Type (Central Machines {Dual-Energy X-Ray Absorptiometry (DXA), Quantitative Computed Tomography (QCT)}, Peripheral Machines {Peripheral Dual-Energy X-Ray Absorptiometry (pDXA), Quantitative Ultrasound (QUS), Peripheral Quantitative Computed Tomography (pQCT)}), Application (Osteopenia and Osteoporosis, Cystic Fibrosis, Rheumatoid Arthritis), End User (Hospitals & Specialty Clinics, Diagnostic & Imaging Centers, Other) Players and Region - Global Market Outlook to 2027

Bone Density Testing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Bone Density Testing?
A bone density test is carried out to identify if patients have osteoporosis a disorder characterized by bones that are more fragile and more likely to break. These tests were carried out with help of X-rays to measure how many grams of calcium and other bone minerals are packed into a segment of bone. A big scanning arm will be passed over the body throughout the scan to determine bone density in the skeleton's center. A small beam of low-dose X-rays will be sent through the region of the body being inspected as the scanning arm moves gently across the body.

The market study is broken down by Type (Central Machines {Dual-Energy X-Ray Absorptiometry (DXA), Quantitative Computed Tomography (QCT)} and Peripheral Machines {Peripheral Dual-Energy X-Ray Absorptiometry (pDXA), Quantitative Ultrasound (QUS), Peripheral Quantitative Computed Tomography (pQCT)}), by Application (Osteopenia and Osteoporosis, Cystic Fibrosis and Rheumatoid Arthritis) and major geographies with country level break-up.

The increasing number of competitors likely to enter the global market is expected to increase competition while also encouraging market expansion in the near future. Players are expected to concentrate on the development of new compounds, which would likely drive the global market forward throughout the forecast period. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Bone Density Testing market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Beammed Ltd. (Israel), CompuMed, Inc. (United States), GE Healthcare (United States), Hologic, Inc. (United States), Osteometer MediTech, Inc. (United States), Hologic Inc. (United States), Osteosys Corp (South Korea), Swissray (United States), DMS Imaging (France), Medonica Co. LLT (South Korea) and One Oak Medical (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Bone Density Testing market by Type, Application and Region.

On the basis of geography, the market of Bone Density Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals & Specialty Clinics will boost the Bone Density Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In May 2019- Hologic, Inc. announced that they have signed an agreement with DEXA+ to distribute Hologic’s Horizon DXA system products for body composition measurement.


Market Trend
  • Growing Demand for Portable Bone Testing Devices

Market Drivers
  • Rising prevalence of Osteopenia and Osteoporosis

Opportunities
  • Increasing Populations Addicted To Smoking Cigarettes and Heavy Drinking

Restraints
  • Side effects of radiation exposure

Challenges
  • Lack of standardization in bone and soft tissue measurements


Key Target Audience
Industry associations, Research organizations and consulting companies, Organizations, associations, and alliances related to the Bone Density Testing, Bone Density Testing device manufacturers, Hospitals and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Central Machines {Dual-Energy X-Ray Absorptiometry (DXA), Quantitative Computed Tomography (QCT)}
  • Peripheral Machines {Peripheral Dual-Energy X-Ray Absorptiometry (pDXA), Quantitative Ultrasound (QUS), Peripheral Quantitative Computed Tomography (pQCT)}
By Application
  • Osteopenia and Osteoporosis
  • Cystic Fibrosis
  • Rheumatoid Arthritis
By End User
  • Hospitals & Specialty Clinics
  • Diagnostic & Imaging Centers
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising prevalence of Osteopenia and Osteoporosis
    • 3.3. Market Challenges
      • 3.3.1. Lack of standardization in bone and soft tissue measurements
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Portable Bone Testing Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bone Density Testing, by Type, Application, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Bone Density Testing (Value)
      • 5.2.1. Global Bone Density Testing by: Type (Value)
        • 5.2.1.1. Central Machines {Dual-Energy X-Ray Absorptiometry (DXA), Quantitative Computed Tomography (QCT)}
        • 5.2.1.2. Peripheral Machines {Peripheral Dual-Energy X-Ray Absorptiometry (pDXA), Quantitative Ultrasound (QUS), Peripheral Quantitative Computed Tomography (pQCT)}
      • 5.2.2. Global Bone Density Testing by: Application (Value)
        • 5.2.2.1. Osteopenia and Osteoporosis
        • 5.2.2.2. Cystic Fibrosis
        • 5.2.2.3. Rheumatoid Arthritis
      • 5.2.3. Global Bone Density Testing by: End User (Value)
        • 5.2.3.1. Hospitals & Specialty Clinics
        • 5.2.3.2. Diagnostic & Imaging Centers
        • 5.2.3.3. Other
      • 5.2.4. Global Bone Density Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Bone Density Testing (Price)
      • 5.3.1. Global Bone Density Testing by: Type (Price)
  • 6. Bone Density Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Beammed Ltd. (Israel)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. CompuMed, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hologic, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Osteometer MediTech, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hologic Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Osteosys Corp (South Korea)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Swissray (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. DMS Imaging (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Medonica Co. LLT (South Korea)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. One Oak Medical (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Bone Density Testing Sale, by Type, Application, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Bone Density Testing (Value)
      • 7.2.1. Global Bone Density Testing by: Type (Value)
        • 7.2.1.1. Central Machines {Dual-Energy X-Ray Absorptiometry (DXA), Quantitative Computed Tomography (QCT)}
        • 7.2.1.2. Peripheral Machines {Peripheral Dual-Energy X-Ray Absorptiometry (pDXA), Quantitative Ultrasound (QUS), Peripheral Quantitative Computed Tomography (pQCT)}
      • 7.2.2. Global Bone Density Testing by: Application (Value)
        • 7.2.2.1. Osteopenia and Osteoporosis
        • 7.2.2.2. Cystic Fibrosis
        • 7.2.2.3. Rheumatoid Arthritis
      • 7.2.3. Global Bone Density Testing by: End User (Value)
        • 7.2.3.1. Hospitals & Specialty Clinics
        • 7.2.3.2. Diagnostic & Imaging Centers
        • 7.2.3.3. Other
      • 7.2.4. Global Bone Density Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Bone Density Testing (Price)
      • 7.3.1. Global Bone Density Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bone Density Testing: by Type(USD Million)
  • Table 2. Bone Density Testing Central Machines {Dual-Energy X-Ray Absorptiometry (DXA), Quantitative Computed Tomography (QCT)} , by Region USD Million (2016-2021)
  • Table 3. Bone Density Testing Peripheral Machines {Peripheral Dual-Energy X-Ray Absorptiometry (pDXA), Quantitative Ultrasound (QUS), Peripheral Quantitative Computed Tomography (pQCT)} , by Region USD Million (2016-2021)
  • Table 4. Bone Density Testing: by Application(USD Million)
  • Table 5. Bone Density Testing Osteopenia and Osteoporosis , by Region USD Million (2016-2021)
  • Table 6. Bone Density Testing Cystic Fibrosis , by Region USD Million (2016-2021)
  • Table 7. Bone Density Testing Rheumatoid Arthritis , by Region USD Million (2016-2021)
  • Table 8. Bone Density Testing: by End User(USD Million)
  • Table 9. Bone Density Testing Hospitals & Specialty Clinics , by Region USD Million (2016-2021)
  • Table 10. Bone Density Testing Diagnostic & Imaging Centers , by Region USD Million (2016-2021)
  • Table 11. Bone Density Testing Other , by Region USD Million (2016-2021)
  • Table 12. South America Bone Density Testing, by Country USD Million (2016-2021)
  • Table 13. South America Bone Density Testing, by Type USD Million (2016-2021)
  • Table 14. South America Bone Density Testing, by Application USD Million (2016-2021)
  • Table 15. South America Bone Density Testing, by End User USD Million (2016-2021)
  • Table 16. Brazil Bone Density Testing, by Type USD Million (2016-2021)
  • Table 17. Brazil Bone Density Testing, by Application USD Million (2016-2021)
  • Table 18. Brazil Bone Density Testing, by End User USD Million (2016-2021)
  • Table 19. Argentina Bone Density Testing, by Type USD Million (2016-2021)
  • Table 20. Argentina Bone Density Testing, by Application USD Million (2016-2021)
  • Table 21. Argentina Bone Density Testing, by End User USD Million (2016-2021)
  • Table 22. Rest of South America Bone Density Testing, by Type USD Million (2016-2021)
  • Table 23. Rest of South America Bone Density Testing, by Application USD Million (2016-2021)
  • Table 24. Rest of South America Bone Density Testing, by End User USD Million (2016-2021)
  • Table 25. Asia Pacific Bone Density Testing, by Country USD Million (2016-2021)
  • Table 26. Asia Pacific Bone Density Testing, by Type USD Million (2016-2021)
  • Table 27. Asia Pacific Bone Density Testing, by Application USD Million (2016-2021)
  • Table 28. Asia Pacific Bone Density Testing, by End User USD Million (2016-2021)
  • Table 29. China Bone Density Testing, by Type USD Million (2016-2021)
  • Table 30. China Bone Density Testing, by Application USD Million (2016-2021)
  • Table 31. China Bone Density Testing, by End User USD Million (2016-2021)
  • Table 32. Japan Bone Density Testing, by Type USD Million (2016-2021)
  • Table 33. Japan Bone Density Testing, by Application USD Million (2016-2021)
  • Table 34. Japan Bone Density Testing, by End User USD Million (2016-2021)
  • Table 35. India Bone Density Testing, by Type USD Million (2016-2021)
  • Table 36. India Bone Density Testing, by Application USD Million (2016-2021)
  • Table 37. India Bone Density Testing, by End User USD Million (2016-2021)
  • Table 38. South Korea Bone Density Testing, by Type USD Million (2016-2021)
  • Table 39. South Korea Bone Density Testing, by Application USD Million (2016-2021)
  • Table 40. South Korea Bone Density Testing, by End User USD Million (2016-2021)
  • Table 41. Taiwan Bone Density Testing, by Type USD Million (2016-2021)
  • Table 42. Taiwan Bone Density Testing, by Application USD Million (2016-2021)
  • Table 43. Taiwan Bone Density Testing, by End User USD Million (2016-2021)
  • Table 44. Australia Bone Density Testing, by Type USD Million (2016-2021)
  • Table 45. Australia Bone Density Testing, by Application USD Million (2016-2021)
  • Table 46. Australia Bone Density Testing, by End User USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Bone Density Testing, by Type USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Bone Density Testing, by Application USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Bone Density Testing, by End User USD Million (2016-2021)
  • Table 50. Europe Bone Density Testing, by Country USD Million (2016-2021)
  • Table 51. Europe Bone Density Testing, by Type USD Million (2016-2021)
  • Table 52. Europe Bone Density Testing, by Application USD Million (2016-2021)
  • Table 53. Europe Bone Density Testing, by End User USD Million (2016-2021)
  • Table 54. Germany Bone Density Testing, by Type USD Million (2016-2021)
  • Table 55. Germany Bone Density Testing, by Application USD Million (2016-2021)
  • Table 56. Germany Bone Density Testing, by End User USD Million (2016-2021)
  • Table 57. France Bone Density Testing, by Type USD Million (2016-2021)
  • Table 58. France Bone Density Testing, by Application USD Million (2016-2021)
  • Table 59. France Bone Density Testing, by End User USD Million (2016-2021)
  • Table 60. Italy Bone Density Testing, by Type USD Million (2016-2021)
  • Table 61. Italy Bone Density Testing, by Application USD Million (2016-2021)
  • Table 62. Italy Bone Density Testing, by End User USD Million (2016-2021)
  • Table 63. United Kingdom Bone Density Testing, by Type USD Million (2016-2021)
  • Table 64. United Kingdom Bone Density Testing, by Application USD Million (2016-2021)
  • Table 65. United Kingdom Bone Density Testing, by End User USD Million (2016-2021)
  • Table 66. Netherlands Bone Density Testing, by Type USD Million (2016-2021)
  • Table 67. Netherlands Bone Density Testing, by Application USD Million (2016-2021)
  • Table 68. Netherlands Bone Density Testing, by End User USD Million (2016-2021)
  • Table 69. Rest of Europe Bone Density Testing, by Type USD Million (2016-2021)
  • Table 70. Rest of Europe Bone Density Testing, by Application USD Million (2016-2021)
  • Table 71. Rest of Europe Bone Density Testing, by End User USD Million (2016-2021)
  • Table 72. MEA Bone Density Testing, by Country USD Million (2016-2021)
  • Table 73. MEA Bone Density Testing, by Type USD Million (2016-2021)
  • Table 74. MEA Bone Density Testing, by Application USD Million (2016-2021)
  • Table 75. MEA Bone Density Testing, by End User USD Million (2016-2021)
  • Table 76. Middle East Bone Density Testing, by Type USD Million (2016-2021)
  • Table 77. Middle East Bone Density Testing, by Application USD Million (2016-2021)
  • Table 78. Middle East Bone Density Testing, by End User USD Million (2016-2021)
  • Table 79. Africa Bone Density Testing, by Type USD Million (2016-2021)
  • Table 80. Africa Bone Density Testing, by Application USD Million (2016-2021)
  • Table 81. Africa Bone Density Testing, by End User USD Million (2016-2021)
  • Table 82. North America Bone Density Testing, by Country USD Million (2016-2021)
  • Table 83. North America Bone Density Testing, by Type USD Million (2016-2021)
  • Table 84. North America Bone Density Testing, by Application USD Million (2016-2021)
  • Table 85. North America Bone Density Testing, by End User USD Million (2016-2021)
  • Table 86. United States Bone Density Testing, by Type USD Million (2016-2021)
  • Table 87. United States Bone Density Testing, by Application USD Million (2016-2021)
  • Table 88. United States Bone Density Testing, by End User USD Million (2016-2021)
  • Table 89. Canada Bone Density Testing, by Type USD Million (2016-2021)
  • Table 90. Canada Bone Density Testing, by Application USD Million (2016-2021)
  • Table 91. Canada Bone Density Testing, by End User USD Million (2016-2021)
  • Table 92. Mexico Bone Density Testing, by Type USD Million (2016-2021)
  • Table 93. Mexico Bone Density Testing, by Application USD Million (2016-2021)
  • Table 94. Mexico Bone Density Testing, by End User USD Million (2016-2021)
  • Table 95. Bone Density Testing: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Bone Density Testing: by Type(USD Million)
  • Table 108. Bone Density Testing Central Machines {Dual-Energy X-Ray Absorptiometry (DXA), Quantitative Computed Tomography (QCT)} , by Region USD Million (2022-2027)
  • Table 109. Bone Density Testing Peripheral Machines {Peripheral Dual-Energy X-Ray Absorptiometry (pDXA), Quantitative Ultrasound (QUS), Peripheral Quantitative Computed Tomography (pQCT)} , by Region USD Million (2022-2027)
  • Table 110. Bone Density Testing: by Application(USD Million)
  • Table 111. Bone Density Testing Osteopenia and Osteoporosis , by Region USD Million (2022-2027)
  • Table 112. Bone Density Testing Cystic Fibrosis , by Region USD Million (2022-2027)
  • Table 113. Bone Density Testing Rheumatoid Arthritis , by Region USD Million (2022-2027)
  • Table 114. Bone Density Testing: by End User(USD Million)
  • Table 115. Bone Density Testing Hospitals & Specialty Clinics , by Region USD Million (2022-2027)
  • Table 116. Bone Density Testing Diagnostic & Imaging Centers , by Region USD Million (2022-2027)
  • Table 117. Bone Density Testing Other , by Region USD Million (2022-2027)
  • Table 118. South America Bone Density Testing, by Country USD Million (2022-2027)
  • Table 119. South America Bone Density Testing, by Type USD Million (2022-2027)
  • Table 120. South America Bone Density Testing, by Application USD Million (2022-2027)
  • Table 121. South America Bone Density Testing, by End User USD Million (2022-2027)
  • Table 122. Brazil Bone Density Testing, by Type USD Million (2022-2027)
  • Table 123. Brazil Bone Density Testing, by Application USD Million (2022-2027)
  • Table 124. Brazil Bone Density Testing, by End User USD Million (2022-2027)
  • Table 125. Argentina Bone Density Testing, by Type USD Million (2022-2027)
  • Table 126. Argentina Bone Density Testing, by Application USD Million (2022-2027)
  • Table 127. Argentina Bone Density Testing, by End User USD Million (2022-2027)
  • Table 128. Rest of South America Bone Density Testing, by Type USD Million (2022-2027)
  • Table 129. Rest of South America Bone Density Testing, by Application USD Million (2022-2027)
  • Table 130. Rest of South America Bone Density Testing, by End User USD Million (2022-2027)
  • Table 131. Asia Pacific Bone Density Testing, by Country USD Million (2022-2027)
  • Table 132. Asia Pacific Bone Density Testing, by Type USD Million (2022-2027)
  • Table 133. Asia Pacific Bone Density Testing, by Application USD Million (2022-2027)
  • Table 134. Asia Pacific Bone Density Testing, by End User USD Million (2022-2027)
  • Table 135. China Bone Density Testing, by Type USD Million (2022-2027)
  • Table 136. China Bone Density Testing, by Application USD Million (2022-2027)
  • Table 137. China Bone Density Testing, by End User USD Million (2022-2027)
  • Table 138. Japan Bone Density Testing, by Type USD Million (2022-2027)
  • Table 139. Japan Bone Density Testing, by Application USD Million (2022-2027)
  • Table 140. Japan Bone Density Testing, by End User USD Million (2022-2027)
  • Table 141. India Bone Density Testing, by Type USD Million (2022-2027)
  • Table 142. India Bone Density Testing, by Application USD Million (2022-2027)
  • Table 143. India Bone Density Testing, by End User USD Million (2022-2027)
  • Table 144. South Korea Bone Density Testing, by Type USD Million (2022-2027)
  • Table 145. South Korea Bone Density Testing, by Application USD Million (2022-2027)
  • Table 146. South Korea Bone Density Testing, by End User USD Million (2022-2027)
  • Table 147. Taiwan Bone Density Testing, by Type USD Million (2022-2027)
  • Table 148. Taiwan Bone Density Testing, by Application USD Million (2022-2027)
  • Table 149. Taiwan Bone Density Testing, by End User USD Million (2022-2027)
  • Table 150. Australia Bone Density Testing, by Type USD Million (2022-2027)
  • Table 151. Australia Bone Density Testing, by Application USD Million (2022-2027)
  • Table 152. Australia Bone Density Testing, by End User USD Million (2022-2027)
  • Table 153. Rest of Asia-Pacific Bone Density Testing, by Type USD Million (2022-2027)
  • Table 154. Rest of Asia-Pacific Bone Density Testing, by Application USD Million (2022-2027)
  • Table 155. Rest of Asia-Pacific Bone Density Testing, by End User USD Million (2022-2027)
  • Table 156. Europe Bone Density Testing, by Country USD Million (2022-2027)
  • Table 157. Europe Bone Density Testing, by Type USD Million (2022-2027)
  • Table 158. Europe Bone Density Testing, by Application USD Million (2022-2027)
  • Table 159. Europe Bone Density Testing, by End User USD Million (2022-2027)
  • Table 160. Germany Bone Density Testing, by Type USD Million (2022-2027)
  • Table 161. Germany Bone Density Testing, by Application USD Million (2022-2027)
  • Table 162. Germany Bone Density Testing, by End User USD Million (2022-2027)
  • Table 163. France Bone Density Testing, by Type USD Million (2022-2027)
  • Table 164. France Bone Density Testing, by Application USD Million (2022-2027)
  • Table 165. France Bone Density Testing, by End User USD Million (2022-2027)
  • Table 166. Italy Bone Density Testing, by Type USD Million (2022-2027)
  • Table 167. Italy Bone Density Testing, by Application USD Million (2022-2027)
  • Table 168. Italy Bone Density Testing, by End User USD Million (2022-2027)
  • Table 169. United Kingdom Bone Density Testing, by Type USD Million (2022-2027)
  • Table 170. United Kingdom Bone Density Testing, by Application USD Million (2022-2027)
  • Table 171. United Kingdom Bone Density Testing, by End User USD Million (2022-2027)
  • Table 172. Netherlands Bone Density Testing, by Type USD Million (2022-2027)
  • Table 173. Netherlands Bone Density Testing, by Application USD Million (2022-2027)
  • Table 174. Netherlands Bone Density Testing, by End User USD Million (2022-2027)
  • Table 175. Rest of Europe Bone Density Testing, by Type USD Million (2022-2027)
  • Table 176. Rest of Europe Bone Density Testing, by Application USD Million (2022-2027)
  • Table 177. Rest of Europe Bone Density Testing, by End User USD Million (2022-2027)
  • Table 178. MEA Bone Density Testing, by Country USD Million (2022-2027)
  • Table 179. MEA Bone Density Testing, by Type USD Million (2022-2027)
  • Table 180. MEA Bone Density Testing, by Application USD Million (2022-2027)
  • Table 181. MEA Bone Density Testing, by End User USD Million (2022-2027)
  • Table 182. Middle East Bone Density Testing, by Type USD Million (2022-2027)
  • Table 183. Middle East Bone Density Testing, by Application USD Million (2022-2027)
  • Table 184. Middle East Bone Density Testing, by End User USD Million (2022-2027)
  • Table 185. Africa Bone Density Testing, by Type USD Million (2022-2027)
  • Table 186. Africa Bone Density Testing, by Application USD Million (2022-2027)
  • Table 187. Africa Bone Density Testing, by End User USD Million (2022-2027)
  • Table 188. North America Bone Density Testing, by Country USD Million (2022-2027)
  • Table 189. North America Bone Density Testing, by Type USD Million (2022-2027)
  • Table 190. North America Bone Density Testing, by Application USD Million (2022-2027)
  • Table 191. North America Bone Density Testing, by End User USD Million (2022-2027)
  • Table 192. United States Bone Density Testing, by Type USD Million (2022-2027)
  • Table 193. United States Bone Density Testing, by Application USD Million (2022-2027)
  • Table 194. United States Bone Density Testing, by End User USD Million (2022-2027)
  • Table 195. Canada Bone Density Testing, by Type USD Million (2022-2027)
  • Table 196. Canada Bone Density Testing, by Application USD Million (2022-2027)
  • Table 197. Canada Bone Density Testing, by End User USD Million (2022-2027)
  • Table 198. Mexico Bone Density Testing, by Type USD Million (2022-2027)
  • Table 199. Mexico Bone Density Testing, by Application USD Million (2022-2027)
  • Table 200. Mexico Bone Density Testing, by End User USD Million (2022-2027)
  • Table 201. Bone Density Testing: by Type(USD/Units)
  • Table 202. Research Programs/Design for This Report
  • Table 203. Key Data Information from Secondary Sources
  • Table 204. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bone Density Testing: by Type USD Million (2016-2021)
  • Figure 5. Global Bone Density Testing: by Application USD Million (2016-2021)
  • Figure 6. Global Bone Density Testing: by End User USD Million (2016-2021)
  • Figure 7. South America Bone Density Testing Share (%), by Country
  • Figure 8. Asia Pacific Bone Density Testing Share (%), by Country
  • Figure 9. Europe Bone Density Testing Share (%), by Country
  • Figure 10. MEA Bone Density Testing Share (%), by Country
  • Figure 11. North America Bone Density Testing Share (%), by Country
  • Figure 12. Global Bone Density Testing: by Type USD/Units (2016-2021)
  • Figure 13. Global Bone Density Testing share by Players 2021 (%)
  • Figure 14. Global Bone Density Testing share by Players (Top 3) 2021(%)
  • Figure 15. Global Bone Density Testing share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Beammed Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 18. Beammed Ltd. (Israel) Revenue: by Geography 2021
  • Figure 19. CompuMed, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. CompuMed, Inc. (United States) Revenue: by Geography 2021
  • Figure 21. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 22. GE Healthcare (United States) Revenue: by Geography 2021
  • Figure 23. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Hologic, Inc. (United States) Revenue: by Geography 2021
  • Figure 25. Osteometer MediTech, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Osteometer MediTech, Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Hologic Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Hologic Inc. (United States) Revenue: by Geography 2021
  • Figure 29. Osteosys Corp (South Korea) Revenue, Net Income and Gross profit
  • Figure 30. Osteosys Corp (South Korea) Revenue: by Geography 2021
  • Figure 31. Swissray (United States) Revenue, Net Income and Gross profit
  • Figure 32. Swissray (United States) Revenue: by Geography 2021
  • Figure 33. DMS Imaging (France) Revenue, Net Income and Gross profit
  • Figure 34. DMS Imaging (France) Revenue: by Geography 2021
  • Figure 35. Medonica Co. LLT (South Korea) Revenue, Net Income and Gross profit
  • Figure 36. Medonica Co. LLT (South Korea) Revenue: by Geography 2021
  • Figure 37. One Oak Medical (United States) Revenue, Net Income and Gross profit
  • Figure 38. One Oak Medical (United States) Revenue: by Geography 2021
  • Figure 39. Global Bone Density Testing: by Type USD Million (2022-2027)
  • Figure 40. Global Bone Density Testing: by Application USD Million (2022-2027)
  • Figure 41. Global Bone Density Testing: by End User USD Million (2022-2027)
  • Figure 42. South America Bone Density Testing Share (%), by Country
  • Figure 43. Asia Pacific Bone Density Testing Share (%), by Country
  • Figure 44. Europe Bone Density Testing Share (%), by Country
  • Figure 45. MEA Bone Density Testing Share (%), by Country
  • Figure 46. North America Bone Density Testing Share (%), by Country
  • Figure 47. Global Bone Density Testing: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Beammed Ltd. (Israel)
  • CompuMed, Inc. (United States)
  • GE Healthcare (United States)
  • Hologic, Inc. (United States)
  • Osteometer MediTech, Inc. (United States)
  • Hologic Inc. (United States)
  • Osteosys Corp (South Korea)
  • Swissray (United States)
  • DMS Imaging (France)
  • Medonica Co. LLT (South Korea)
  • One Oak Medical (United States)
Select User Access Type

Key Highlights of Report


Mar 2022 243 Pages 96 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bone Density Testing Market Quantitative research analysis
Global Bone Density Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Beammed Ltd. (Israel), CompuMed, Inc. (United States), GE Healthcare (United States), Hologic, Inc. (United States), Osteometer MediTech, Inc. (United States), Hologic Inc. (United States), Osteosys Corp (South Korea), Swissray (United States), DMS Imaging (France), Medonica Co. LLT (South Korea) and One Oak Medical (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Bone Density Testing Market to reach USD Million by 2027.

Know More About Global Bone Density Testing Market Report?

Have a Query? Click Here

Other Related Reports

Arthroscope Implants Comprehensive Study by Type (Knee Implants, Hip Implants, Shoulder Implants, Other), Application (Knee, Hip, Spine, Foot & Ankle, Other), End-users (Hospitals, Ambulatory surgica...
$ 3500
Alpha Emitters Comprehensive Study by Application (Pancreatic Cancer, Prostate Cancer, Ovarian Cancer, Other), Radionuclide Type (Fermium, Astatine, Curium, Radium, Actinium, Radon, Bismuth, Other), ...
$ 3500
Emerging Mental Health Device and Platform Comprehensive Study by Type (Platforms, Devices), Application (Stress, Anxiety, Depression, Bipolar Disorder, Schizophrenia, Others), Therapy (Cognitive Beh...
$ 3800
Shoulder Implants- Comprehensive Study by Implant Type (Anatomical Shoulder Prosthesis, Reverse Shoulder Prosthesis), End-user (Hospitals, Ambulatory Surgical Center, Orthopaedic Clinics) Players an...
$ 3400
Fecal Management System Comprehensive Study by Patient Type (Adult, Pediatric), Product (Colostomy Bags, Irrigation System, Nerve Modulation Devices, Accessories), End-User (Home Care, Hospitals, Am...
$ 3800
Trench Fever Medicine Comprehensive Study by Type (Doxycycline, Tetracycline, Chloramphenicol, Others), Distribution Channel (Online, Offline), End-User (Hospital, Clinics, Ambulatory Surgical Center...
$ 3500